• If you are wondering whether Intuitive Surgical at around US$452 a share still offers good value or if most of the opportunity has already been priced in, you are not alone.
• The stock is currently around US$452.47, with a 7 day return of a 1.8% decline, a 30 day return of a 7.7% decline, a year to date return of a 19.5% decline, a 1 year return of a 1.1% decline, and a 3 year return of 72.2% and a 5 year return of 70.9%.
• Recent coverage has focused on Intuitive Surgical's position in robotic assisted surgery and on how the broader medical equipment sector is being priced. This helps frame the recent share price moves. Headlines have also highlighted investor focus on long term procedure growth, capital equipment demand, and how those themes are reflected in current market expectations.
• On Simply Wall St's valuation checks, Intuitive Surgical scores 1 out of 6. The rest of this article will walk through what that means across different valuation methods and then finish with a framework that can help you think about value in an even more complete way.

Intuitive Surgical scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Intuitive Surgical Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company might be worth by projecting its future cash flows and then discounting those back to today using a required return. It is essentially asking what those future dollars are worth in present terms.

For Intuitive Surgical, the latest twelve month Free Cash Flow (FCF) is around $1.96b. Analysts and Simply Wall St projections point to FCF reaching about $6.08b in 2030, with estimates provided out to 2030 and then extrapolated further using a 2 Stage Free Cash Flow to Equity approach.

When all those projected cash flows are discounted back and added up, the model arrives at an estimated intrinsic value of about $367.72 per share. Compared with the current share price of around $452, the DCF output suggests the stock is about 23.0% overvalued based on these cash flow assumptions.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Intuitive Surgical may be overvalued by 23.0%. Discover 61 high quality undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Intuitive Surgical.

Approach 2: Intuitive Surgical Price vs Earnings

For a profitable company like Intuitive Surgical, the P/E ratio is a useful way to think about what you are paying for each dollar of earnings. Higher expected growth and lower perceived risk usually support a higher P/E, while slower growth or higher risk tend to align with a lower, more conservative multiple.

Intuitive Surgical currently trades on a P/E of about 56.3x. That is well above the Medical Equipment industry average of around 26.7x and also above the peer group average of roughly 30.6x. On those simple comparisons, the shares look expensive relative to many listed medical equipment companies.

Simply Wall St's Fair Ratio metric suggests a P/E of about 35.1x for Intuitive Surgical, based on factors such as earnings growth, profit margins, industry, market cap and company specific risks. This Fair Ratio can be more useful than a basic peer or industry comparison because it adjusts for the profile of the individual company rather than assuming all peers deserve similar multiples. Compared with the current 56.3x, the Fair Ratio points to the shares trading richer than what those fundamentals alone might support.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Intuitive Surgical Narrative

Earlier it was mentioned that there is an even better way to understand valuation, and on Simply Wall St that takes the form of Narratives. You choose or build a story for Intuitive Surgical that links its business drivers to specific forecasts for revenue, margins and earnings. These then roll into a Fair Value that can be compared with the current share price to help you decide whether the stock looks attractive or stretched. All of this happens within an easy to use Community page where Narratives are refreshed when new data arrives and where very different views can coexist. For example, one Narrative currently sees Fair Value at about US$325.55 and another at about US$750. This reflects how two investors can look at the same company, plug in different assumptions, and reach very different conclusions about what Intuitive Surgical is worth.

For Intuitive Surgical however we will make it really easy for you with previews of two leading Intuitive Surgical Narratives:

🐂 Intuitive Surgical Bull Case

Fair value in this narrative: US$532.46 per share

Gap to that fair value: around 15.0% above the current US$452.47 share price

Revenue growth assumption: 12%

• The author sees Intuitive Surgical as a long term compounder built around the da Vinci ecosystem and high margin, recurring revenue from instruments, services, and software.
• This view highlights a large installed base, rising procedure volumes, and a business model that leans heavily on subscription like revenue from replacement parts and licences.
• The narrative argues that quality and resilience justify paying close to what is viewed as fair value, while also flagging that the shares often trade at what the author considers a premium.

🐻 Intuitive Surgical Bear Case

Fair value in this narrative: US$325.55 per share

Overvaluation vs that fair value: around 28.9% at the current US$452.47 share price

Revenue growth assumption: 12%

• This narrative accepts that Intuitive Surgical has a strong position in robotic surgery, but sees the current valuation as rich relative to growth, margins, and execution risks.
• Key risks highlighted include high upfront system costs, regulatory and reimbursement uncertainty, reliance on the da Vinci platform, and potential competition from new robotic systems.
• The author stresses that premium P/E multiples leave little room for disappointment and that any slowdown in procedure growth or margin pressure could hit the share price hard.

Between these two Narratives, you can see how the same company story leads to very different views on value, return potential, and risk tolerance. This contrast can help you sharpen your own stance on Intuitive Surgical stock.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Intuitive Surgical on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for Intuitive Surgical? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.